/* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .footer { background: #f5f5f6; color: #555a62; font-size: 14px; line-height: 1.5; padding: 18px 0; } .footer-wrap { padding-left: 18px; padding-right: 18px; max-width: 1236px; margin: 0 auto; } .footer a { color: #0291db; } .footer a:hover { color: #0276b3; } .footer-row { display: flex; flex-wrap: wrap; justify-content: space-between; align-items: center; margin: -3px; } .footer-col { padding: 0 3px; } .footer-col-copyRight { justify-content: flex-start; } .footer-col-logo { justify-content: flex-end; } .footer-col-copyRight, .footer-col-logo { flex: 1; display: flex; } .logo { width: 120px; height: 28px; opacity: 0.6; } @media screen and (max-width: 768px) { .footer-row { display: block; } .footer-col { width: 100%; text-align: center; margin: 6px 0; } .footer-col:first-child { margin-top: 0; } .footer-col:last-child { margin-bottom: 0; } .footer-col-copyRight, .footer-col-logo { justify-content: center; } .logo { margin: 0 auto; } } /*# sourceMappingURL=styles.css.map */ /* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .region.region-footer { background-color: #1E1E23; padding: 20px; text-align: center; } .region.region-footer .block { max-width: 1264px; margin: 10px auto; color: #dddddd; } .region.region-footer .block a { color: #dddddd; font-size: 17px; } .region.region-footer .block a:hover, .csnfooter.small:hover { color: #ffffff; } #footer-links span.sep { color: rgb(151, 174, 206); font-size: 8px; display: inline-block; margin: 0 10px; line-height: 18px; vertical-align: text-top; } .csnfooter.small { font-size: 13px; margin-bottom: 15px; text-align: center; } @media only screen and (min-width: 768px) { .csnfooter.small { width: calc(100% - 348px); } } /*# sourceMappingURL=styles.css.map */ <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W7KNSFJ" height="0" width="0" style="display:none;visibility:hidden"></iframe>

Lenvima/Lenvatinib

Williamryan

Williamryan Member Posts: 37

April 2015 in Thyroid Cancer #1

Lenvima/lenvatinib has just been approved for papillary thyroid cancer treatment that is resistant to RI-131. It just came off of clinical trials and the FDA had put it on the fast track for approval. Has anyone tried this new chemo pill? My oncologist is recommending this for me since Nexavar and Zelboraf had no effect on me.

Thanks,

Bill

0

/* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .footer { background: #f5f5f6; color: #555a62; font-size: 14px; line-height: 1.5; padding: 18px 0; } .footer-wrap { padding-left: 18px; padding-right: 18px; max-width: 1236px; margin: 0 auto; } .footer a { color: #0291db; } .footer a:hover { color: #0276b3; } .footer-row { display: flex; flex-wrap: wrap; justify-content: space-between; align-items: center; margin: -3px; } .footer-col { padding: 0 3px; } .footer-col-copyRight { justify-content: flex-start; } .footer-col-logo { justify-content: flex-end; } .footer-col-copyRight, .footer-col-logo { flex: 1; display: flex; } .logo { width: 120px; height: 28px; opacity: 0.6; } @media screen and (max-width: 768px) { .footer-row { display: block; } .footer-col { width: 100%; text-align: center; margin: 6px 0; } .footer-col:first-child { margin-top: 0; } .footer-col:last-child { margin-bottom: 0; } .footer-col-copyRight, .footer-col-logo { justify-content: center; } .logo { margin: 0 auto; } } /*# sourceMappingURL=styles.css.map */ /* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .region.region-footer { background-color: #1E1E23; padding: 20px; text-align: center; } .region.region-footer .block { max-width: 1264px; margin: 10px auto; color: #dddddd; } .region.region-footer .block a { color: #dddddd; font-size: 17px; } .region.region-footer .block a:hover, .csnfooter.small:hover { color: #ffffff; } #footer-links span.sep { color: rgb(151, 174, 206); font-size: 8px; display: inline-block; margin: 0 10px; line-height: 18px; vertical-align: text-top; } .csnfooter.small { font-size: 13px; margin-bottom: 15px; text-align: center; } @media only screen and (min-width: 768px) { .csnfooter.small { width: calc(100% - 348px); } } /*# sourceMappingURL=styles.css.map */

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2023 © Cancer Survivors Network